vs
Side-by-side financial comparison of ECARX Holdings Inc. (ECX) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
ECARX Holdings Inc. is the larger business by last-quarter revenue ($323.3M vs $207.8M, roughly 1.6× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -21.4%, a 78.7% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-86.5M).
ECARX Holdings Inc. is a global mobility technology provider specializing in integrated smart vehicle solutions, including in-vehicle infotainment systems, advanced driver assistance technologies, and connected car cloud services. It primarily partners with automotive manufacturers across the world, with a strong operational presence in the Chinese and European markets.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
ECX vs IDYA — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $323.3M | $207.8M |
| Net Profit | $-69.1M | $119.2M |
| Gross Margin | 15.5% | — |
| Operating Margin | -20.2% | 52.2% |
| Net Margin | -21.4% | 57.4% |
| Revenue YoY | 6.5% | — |
| Net Profit YoY | 12.8% | 330.1% |
| EPS (diluted) | $-0.20 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $207.8M | ||
| Q2 25 | $323.3M | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | $303.5M | $0 | ||
| Q1 24 | — | $0 | ||
| Q3 22 | — | $29.7M |
| Q3 25 | — | $119.2M | ||
| Q2 25 | $-69.1M | — | ||
| Q3 24 | — | $-51.8M | ||
| Q2 24 | $-79.2M | $-52.8M | ||
| Q1 24 | — | $-39.6M | ||
| Q3 22 | — | $1.6M |
| Q3 25 | — | — | ||
| Q2 25 | 15.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 22.6% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | — |
| Q3 25 | — | 52.2% | ||
| Q2 25 | -20.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -22.2% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | 2.2% |
| Q3 25 | — | 57.4% | ||
| Q2 25 | -21.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -26.1% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | 5.4% |
| Q3 25 | — | $1.33 | ||
| Q2 25 | $-0.20 | — | ||
| Q3 24 | — | $-0.60 | ||
| Q2 24 | $-0.23 | $-0.68 | ||
| Q1 24 | — | $-0.53 | ||
| Q3 22 | — | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.2M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-293.7M | $1.1B |
| Total Assets | $494.9M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $786.9M | ||
| Q2 25 | $86.2M | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | $108.4M | $701.7M | ||
| Q1 24 | — | $698.8M | ||
| Q3 22 | — | $386.2M |
| Q3 25 | — | $1.1B | ||
| Q2 25 | $-293.7M | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $-198.5M | $931.7M | ||
| Q1 24 | — | $935.3M | ||
| Q3 22 | — | $368.8M |
| Q3 25 | — | $1.2B | ||
| Q2 25 | $494.9M | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $555.0M | $973.7M | ||
| Q1 24 | — | $961.5M | ||
| Q3 22 | — | $410.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-82.0M | $142.2M |
| Free Cash FlowOCF − Capex | $-86.5M | $142.2M |
| FCF MarginFCF / Revenue | -26.7% | 68.4% |
| Capex IntensityCapex / Revenue | 1.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $142.2M | ||
| Q2 25 | $-82.0M | — | ||
| Q3 24 | — | $-49.2M | ||
| Q2 24 | $-57.1M | $-32.9M | ||
| Q1 24 | — | $-43.8M | ||
| Q3 22 | — | $-24.2M |
| Q3 25 | — | $142.2M | ||
| Q2 25 | $-86.5M | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | $-64.9M | $-33.9M | ||
| Q1 24 | — | $-45.1M | ||
| Q3 22 | — | $-25.3M |
| Q3 25 | — | 68.4% | ||
| Q2 25 | -26.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -21.4% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | -85.1% |
| Q3 25 | — | 0.0% | ||
| Q2 25 | 1.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | 3.7% |
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | -14.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
